Bioton S.a.
Warsaw Stock Exchange:BIO.WA
Sector
Industries
Location
Market Cap
USD 105.31 M
Share Price
USD 1.21
Avg Daily Volume
67,804
Change (1 day)
-1.61%
Change (1 year)
37.10%
Change (YTD)
71.97%
Bioton S.a. Operating Cash Flow for the year ending December 31, 2022: USD 12.80 M
Bioton S.a. Operating Cash Flow is USD 12.80 M for the year ending December 31, 2022, a 837.03% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Bioton S.a. Operating Cash Flow for the year ending December 31, 2021 was USD 1.37 M, a -87.84% change year over year.
-
Bioton S.a. Operating Cash Flow for the year ending December 31, 2020 was USD 11.23 M, a -8.62% change year over year.
-
Bioton S.a. Operating Cash Flow for the year ending December 31, 2019 was USD 12.29 M, a 65.14% change year over year.
-
Bioton S.a. Operating Cash Flow for the year ending December 31, 2018 was USD 7.44 M.
StockViz
Competitors
Eli Lilly and Company
USD 625.65
LLY
-15.21
-2.37%
AbbVie Inc.
USD 198.05
ABBV
-0.81
-0.41%
Roche Holding AG
USD 318.77
RO.SW
-3.47
-1.08%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Abbott Laboratories
USD 134.28
ABT
+2.22
1.68%
Novartis AG
USD 116.31
NOVN.SW
+1.16
1.00%
Novo Nordisk A/S
USD 50.40
NOVO-B.CO
+2.25
4.67%
Merck & Co., Inc.
USD 80.69
MRK
+0.32
0.40%
Thermo Fisher Scientific Inc.
USD 460.72
TMO
+5.98
1.31%
Amgen Inc.
USD 288.23
AMGN
+3.53
1.24%
Pfizer Inc.
USD 24.58
PFE
+0.35
1.44%
Gilead Sciences, Inc.
USD 119.41
GILD
+9.13
8.28%
Sanofi
USD 94.22
SAN.PA
-0.08
-0.08%
Vertex Pharmaceuticals Incorporated
USD 366.54
VRTX
-9.09
-2.42%
Bristol-Myers Squibb Company
USD 45.95
BMY
+0.59
1.30%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Eli Lilly and Company
USD 625.65
LLY
-15.21
-2.37%
AbbVie Inc.
USD 198.05
ABBV
-0.81
-0.41%
Roche Holding AG
USD 318.77
RO.SW
-3.47
-1.08%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Abbott Laboratories
USD 134.28
ABT
+2.22
1.68%
Novartis AG
USD 116.31
NOVN.SW
+1.16
1.00%
Novo Nordisk A/S
USD 50.40
NOVO-B.CO
+2.25
4.67%
Merck & Co., Inc.
USD 80.69
MRK
+0.32
0.40%
Thermo Fisher Scientific Inc.
USD 460.72
TMO
+5.98
1.31%
Amgen Inc.
USD 288.23
AMGN
+3.53
1.24%
Pfizer Inc.
USD 24.58
PFE
+0.35
1.44%
Gilead Sciences, Inc.
USD 119.41
GILD
+9.13
8.28%
Sanofi
USD 94.22
SAN.PA
-0.08
-0.08%
Vertex Pharmaceuticals Incorporated
USD 366.54
VRTX
-9.09
-2.42%
Bristol-Myers Squibb Company
USD 45.95
BMY
+0.59
1.30%